358 related articles for article (PubMed ID: 33466626)
1. The Taming of Nuclear Factor Erythroid-2-Related Factor-2 (Nrf2) Deglycation by Fructosamine-3-Kinase (FN3K)-Inhibitors-A Novel Strategy to Combat Cancers.
Beeraka NM; Bovilla VR; Doreswamy SH; Puttalingaiah S; Srinivasan A; Madhunapantula SV
Cancers (Basel); 2021 Jan; 13(2):. PubMed ID: 33466626
[TBL] [Abstract][Full Text] [Related]
2. Screening fructosamine-3-kinase (FN3K) inhibitors, a deglycating enzyme of oncogenic Nrf2: Human FN3K homology modelling, docking and molecular dynamics simulations.
Beeraka NM; Zhang J; Mandal S; Vikram P R H; Liu J; B M N; Zhao D; Vishwanath P; B M G; Fan R
PLoS One; 2023; 18(11):e0283705. PubMed ID: 37910519
[TBL] [Abstract][Full Text] [Related]
3. Intrinsic toxicity of glucose, due to non-enzymatic glycation, is controlled in-vivo by deglycation systems including: FN3K-mediated deglycation of fructosamines and transglycation of aldosamines.
Szwergold BS
Med Hypotheses; 2005; 65(2):337-48. PubMed ID: 15922110
[TBL] [Abstract][Full Text] [Related]
4. The Oncogenic Action of NRF2 Depends on De-glycation by Fructosamine-3-Kinase.
Sanghvi VR; Leibold J; Mina M; Mohan P; Berishaj M; Li Z; Miele MM; Lailler N; Zhao C; de Stanchina E; Viale A; Akkari L; Lowe SW; Ciriello G; Hendrickson RC; Wendel HG
Cell; 2019 Aug; 178(4):807-819.e21. PubMed ID: 31398338
[TBL] [Abstract][Full Text] [Related]
5. Fructosamine-6-phosphates are deglycated by phosphorylation to fructosamine-3,6-bisphosphates catalyzed by fructosamine-3-kinase (FN3K) and/or fructosamine-3-kinase-related-protein (FN3KRP).
Szwergold BS
Med Hypotheses; 2007; 68(1):37-45. PubMed ID: 16920277
[TBL] [Abstract][Full Text] [Related]
6. Identification of fructosamine residues deglycated by fructosamine-3-kinase in human hemoglobin.
Delpierrre G; Vertommen D; Communi D; Rider MH; Van Schaftingen E
J Biol Chem; 2004 Jun; 279(26):27613-20. PubMed ID: 15102834
[TBL] [Abstract][Full Text] [Related]
7. A Hypothesis: Fructosamine-3-Kinase-Related-Protein (FN3KRP) Catalyzes Deglycation of Maillard Intermediates Directly Downstream from Fructosamines.
Szwergold B
Rejuvenation Res; 2021 Aug; 24(4):310-318. PubMed ID: 34314247
[TBL] [Abstract][Full Text] [Related]
8. Many fructosamine 3-kinase homologues in bacteria are ribulosamine/erythrulosamine 3-kinases potentially involved in protein deglycation.
Gemayel R; Fortpied J; Rzem R; Vertommen D; Veiga-da-Cunha M; Van Schaftingen E
FEBS J; 2007 Sep; 274(17):4360-74. PubMed ID: 17681011
[TBL] [Abstract][Full Text] [Related]
9. Enzymatic deglycation--a new paradigm or an epiphenomenon?
Szwergold BS; Beisswenger PJ
Biochem Soc Trans; 2003 Dec; 31(Pt 6):1428-32. PubMed ID: 14641081
[TBL] [Abstract][Full Text] [Related]
10. Enzymatic Deglycation of Damaged Skin by Means of Combined Treatment of Fructosamine-3-Kinase and Fructosyl-Amino Acid Oxidase.
De Decker I; Notebaert M; Speeckaert MM; Claes KEY; Blondeel P; Van Aken E; Van Dorpe J; De Somer F; Heintz M; Monstrey S; Delanghe JR
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240327
[TBL] [Abstract][Full Text] [Related]
11. A simple colorimetric assay for measuring fructosamine 3 kinase activity.
Cikomola JC; Kishabongo AS; Vandepoele K; Mulder M; Katchunga PB; Laukens B; Schie LV; Grootaert H; Callewaert N; Speeckaert MM; Delanghe JR
Clin Chem Lab Med; 2017 Jan; 55(1):154-159. PubMed ID: 27394048
[TBL] [Abstract][Full Text] [Related]
12. Evidence That Differences in Fructosamine-3-Kinase Activity May Be Associated With the Glycation Gap in Human Diabetes.
Dunmore SJ; Al-Derawi AS; Nayak AU; Narshi A; Nevill AM; Hellwig A; Majebi A; Kirkham P; Brown JE; Singh BM
Diabetes; 2018 Jan; 67(1):131-136. PubMed ID: 29066600
[TBL] [Abstract][Full Text] [Related]
13. Some clues as to the regulation, expression, function, and distribution of fructosamine-3-kinase and fructosamine-3-kinase-related protein.
Conner JR; Beisswenger PJ; Szwergold BS
Ann N Y Acad Sci; 2005 Jun; 1043():824-36. PubMed ID: 16037310
[TBL] [Abstract][Full Text] [Related]
14. Requirement for p38 and p44/p42 mitogen-activated protein kinases in RAGE-mediated nuclear factor-kappaB transcriptional activation and cytokine secretion.
Yeh CH; Sturgis L; Haidacher J; Zhang XN; Sherwood SJ; Bjercke RJ; Juhasz O; Crow MT; Tilton RG; Denner L
Diabetes; 2001 Jun; 50(6):1495-504. PubMed ID: 11375353
[TBL] [Abstract][Full Text] [Related]
15. Human fructosamine-3-kinase: purification, sequencing, substrate specificity, and evidence of activity in vivo.
Szwergold BS; Howell S; Beisswenger PJ
Diabetes; 2001 Sep; 50(9):2139-47. PubMed ID: 11522682
[TBL] [Abstract][Full Text] [Related]
16. Nrf2 deficiency induces oxidative stress and promotes RANKL-induced osteoclast differentiation.
Hyeon S; Lee H; Yang Y; Jeong W
Free Radic Biol Med; 2013 Dec; 65():789-799. PubMed ID: 23954472
[TBL] [Abstract][Full Text] [Related]
17. Counteracting role of nuclear factor erythroid 2-related factor 2 pathway in Alzheimer's disease.
Sharma V; Kaur A; Singh TG
Biomed Pharmacother; 2020 Sep; 129():110373. PubMed ID: 32603894
[TBL] [Abstract][Full Text] [Related]
18. Fructosamine-3-kinase-related-protein phosphorylates glucitolamines on the C-4 hydroxyl: novel substrate specificity of an enigmatic enzyme.
Szwergold B; Manevich Y; Payne L; Loomes K
Biochem Biophys Res Commun; 2007 Oct; 361(4):870-5. PubMed ID: 17686456
[TBL] [Abstract][Full Text] [Related]
19. Alpha-thiolamines such as cysteine and cysteamine act as effective transglycating agents due to formation of irreversible thiazolidine derivatives.
Szwergold BS
Med Hypotheses; 2006; 66(4):698-707. PubMed ID: 16359826
[TBL] [Abstract][Full Text] [Related]
20. Sirt1 resists advanced glycation end products-induced expressions of fibronectin and TGF-β1 by activating the Nrf2/ARE pathway in glomerular mesangial cells.
Huang K; Huang J; Xie X; Wang S; Chen C; Shen X; Liu P; Huang H
Free Radic Biol Med; 2013 Dec; 65():528-540. PubMed ID: 23891678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
